Does a higher dietary omega-6:omega-3 ratio promote vascular inflammation?

An elevated dietary and tissue omega-6:omega-3 polyunsaturated fatty acid (PUFA) ratio is strongly associated with an increased susceptibility to vascular inflammation due to its direct role in shifting the lipid mediator balance.

Clinical and mechanical lipid mediator balance

• Competitive enzyme inhibition: Omega-6 and omega-3 fatty acids utilize and compete for the exact same cellular machinery, specifically the cyclooxygenase (COX) and lipoxygenase (LOX) enzymes. Under conditions of an elevated omega-6:omega-3 ratio, arachidonic acid (AA, an omega-6 PUFA) acts as the dominant substrate. This biochemically favors the production of pro-inflammatory lipid mediators (such as 2-series prostaglandins like $PGE_2$ and 4-series leukotrienes like $LTB_4$).
• Inhibition of resolution pathways: Conversely, a lower ratio shifts this competitive balance toward omega-3-derived mediators, generating less-active 3-series prostaglandins ($PGE_3$), 5-series leukotrienes, and protective specialized pro-resolving mediators (SPMs) such as resolvins, protectins, and maresins.

Endothelial dysfunction and vascular inflammation

• Endothelial cell activation: A shift toward a pro-inflammatory lipid profile directly impacts vascular biology. High levels of $PGE_2$ activate the cAMP/Epac signaling pathway in endothelial cells.
• Leukocyte recruitment: This activation upregulates the expression of critical endothelial cell adhesion molecules, specifically intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). Concurrently, $LTB_4$ acts as a highly potent chemoattractant, promoting the recruitment, firm adhesion, and transendothelial migration of leukocytes into the vascular wall, which perpetuates chronic vascular injury.

Bottom line

An elevated omega-6:omega-3 ratio is a significant driver of a pro-inflammatory lipid mediator balance, which directly promotes endothelial activation, cell adhesion molecule expression (ICAM-1 and VCAM-1), and leukocyte recruitment, thereby contributing to vascular inflammation and the progression of cardiovascular pathology.